| Literature DB >> 31073996 |
Jiayu Peng1, Zhuo Meng1,2, Shuang Zhou1, Yue Zhou1, Yujian Wu1, Qingjie Wang1, Jian Wang1, Kun Sun1,2.
Abstract
BACKGROUND: Advances have been made in identifying genetic etiologies and maternal risk factors of congenital heart defects (CHDs), while few literatures are available regarding paternal risk factors for CHDs. Thus, we aim to conduct a meta-analysis and systematic review about the non-genetic paternal risk factors for CHDs.Entities:
Keywords: congenital heart defects; meta-analysis; paternal risk factors
Mesh:
Year: 2019 PMID: 31073996 PMCID: PMC6605632 DOI: 10.1002/clc.23194
Source DB: PubMed Journal: Clin Cardiol ISSN: 0160-9289 Impact factor: 2.882
Figure 1Flow chart of study selection process. CI, confidence intervals; OR, odd ratios
The characteristics of the included studies
| Study | Study period | Study location | Study design | No. of cases | No. of controls | Exposure | Cardiac defects | Exposure period | NOS |
|---|---|---|---|---|---|---|---|---|---|
| 2018‐Liu | 2004‐2014 | China | Case‐control | 4726 | 4726 | Drinking | All CHDs | B3‐P3 | 7 |
| 2017‐Li | 2013‐2014 | China | Case‐control | 119 | 239 | Chronic disease | All CHDs | B6 | 6 |
| Exposure to occupational hazards | |||||||||
| 2016‐Silver | 1983‐2001 | USA | Cohort | NA | NA | Age | VSD | B3‐P1 | 8 |
| Metal | VSD | ||||||||
| Lead | VSD | ||||||||
| Chlorinated hydrocarbons | VSD | ||||||||
| 2016‐Ou | 2004‐2013 | China | Case‐control | 4034 | 4034 | Drinking | All CHDs | B3‐P3 | 7 |
| 1566 | 4034 | Drinking | VSD | 7 | |||||
| 1028 | 4034 | Drinking | ASD | ||||||
| 212 | 4034 | Drinking | PA | ||||||
| 143 | 4034 | Drinking | TGA | ||||||
| 2016‐Liu | 2014‐2015 | China | Case‐control | 80 | 160 | Drinking | All CHDs | B6 | 7 |
| Smoking | |||||||||
| Age | |||||||||
| 2016‐Abqari | 2014–2015 | India | Case‐control | 400 | 754 | Age | All CHDs | ‐ | 6 |
| 2015‐Wang | 2012‐2013 | China | Case‐control | 761 | 609 | Age | All CHDs | B3‐P3 | 8 |
| Smoking | |||||||||
| Drinking | |||||||||
| Pesticides | |||||||||
| Polychlorinated compounds | |||||||||
| Phthalates | |||||||||
| Alkylphenolic compounds | |||||||||
| Bisphenol A | |||||||||
| Heavy metals | |||||||||
| 2015‐Qu | 2004‐2012 | China | Case‐control | 3038 | 3038 | Occupation | All CHDs | B3 | 8 |
| 2015‐Chen | 2012–2013 | China | Case‐control | 435 | 574 | Age | All CHDs | ‐ | 6 |
| 2014‐Wijnands | 2013‐ | Netherlands | Case‐control | 114 | 484 | Phthalates | All CHDs | B1‐P2 | 6 |
| 2013‐Nie | 2004‐2011 | China | Case‐control | 2568 | 2568 | Antibiotics | All CHDs | B3 | 7 |
| Drinking | |||||||||
| Chemical agent contact | |||||||||
| Smoking | |||||||||
| Virus infection | |||||||||
| Age | |||||||||
| 2013‐Fung | 2008‐2011 | Canada | Case‐control | 1339 | 199 | Smoking | All CHDs | B3‐P3 | 6 |
| 2013‐Deng | 2010‐2012 | China | Case‐control | 284 | 422 | Smoking | All CHDs | B3‐P3 | 6 |
| 75 | 147 | Smoking | Septal defects | ||||||
| 72 | 147 | Smoking | Conotruncal defects | ||||||
| 31 | 147 | Smoking | LVOTO | ||||||
| 28 | 147 | Smoking | RVOTO | ||||||
| 2012‐Snijder | 2003‐2010 | The Netherlands | Case‐control | 421 | 477 | Pesticides | All CHDs | B1‐P2 | 8 |
| Polychlorinated compounds | |||||||||
| Phthalates | |||||||||
| AlkylphenOlic compounds | |||||||||
| Heavy metals | |||||||||
| 2012‐Chehab | 2006‐2010 | France | Case‐control | 2466 | 793 | smoking | All CHDs | NA | 6 |
| 2011‐Karatza | 2006‐2009 | Greek | Case‐control | 157 | 208 | Smoking | All CHDs | B1‐P3 | 7 |
| 2011‐Cresci | 2008‐2010 | Italy | Case‐control | 330 | 330 | Diagnostic X‐ray exposure | All CHDs | B3 | 6 |
| Drinking | |||||||||
| Exposure to toxicants | |||||||||
| 2010‐Kuciene | 1995‐2005 | Lithuania | Case‐control | 261 | 1122 | Smoking | All CHDs | ‐ | 6 |
| 2010‐Green | 1997‐2004 | USA | Case‐control | 740 | 5839 | Age | PVS | ‐ | 6 |
| 1011 | 5839 | Age | RVOTO | ||||||
| 2009‐Materna | 1998‐2002 | Poland | Case‐control | 2451 | 6231 | Age | All CHDs | ‐ | 6 |
| 2007‐yang | 1999‐2000 | USA | Cohort | 6797 | 5 360 532 | Age | All CHDs | ‐ | 7 |
| 2006‐Kuehl | 1981‐1989 | USA | Case‐control | 142 | 3572 | Age | HLHS | B6 | 6 |
| 2004‐Kazaura | 1967‐1998 | Norway | Case‐control | 3628 | 13 668 | Age | All CHDs | ‐ | 6 |
| 2002‐Cedergren | 1982‐1996 | Sweden | Case‐control | 269 | 524 | Age | All CHDs | ‐ | 7 |
| 2001‐Loffredo | 1981–1989 | USA | Case‐control | 641 | 3549 | Painting | Isolated membranous VSD | B3‐P3 | 6 |
| 2000‐Bassili | 1995‐1997 | Egypt | Case‐control | 894 | 894 | Age | All CHDs | ‐ | 7 |
| 1997‐Ewing | 1981–1989 | USA | Case‐control | 643 | 3551 | Age | Isolated membranous VSD | B6 | 7 |
| Marijuana use | Isolated membranous VSD | ||||||||
| Cocaine use | Isolated membranous VSD | ||||||||
| Smoking | Isolated membranous VSD | ||||||||
| Drinking | Isolated membranous VSD | ||||||||
| 1996‐Aronson | 1979‐1986 | Canada | Nested Case–control cohort | 9340 | 9340 | Fire fighter | All CHDs | ‐ | 8 |
| 1994‐Olshan | 1952‐1973 | UK | Case‐control | 4110 | 8220 | Age | VSD | ‐ | 7 |
| Age | ASD | ||||||||
| 1991‐Zhan | 1986‐1987 | China | Case–control | 497 | 6222 | Age | All CHDs | ‐ | 7 |
| 1991‐Olshan | 1952–1973 | UK | Case‐control | 1081 | 2272 | Occupation | ASD | ‐ | 7 |
| 657 | 1213 | Occupation | VSD | 8 | |||||
| 1125 | 2309 | Occupation | PDA | ||||||
| 594 | 1256 | Occupation | Other CHDs |
Abbreviations: ASD, atrial septal defect; HLHS, hypoplastic left heart syndrome; LVOTO, left ventricular outflow tract obstructions; NOS, Newcastle‐Ottawa Scale; PA, pulmonary atresia; PDA, patent ductus arteriosus; PVS, pulmonary valve stenosis; RVOTO, right ventricular outflow tract obstructions; TGA, transposition of great artery; VSD, ventricular septal defect.
B#, month before conception, B, unspecified time before conception, P#, month during pregnancy.
The results of subgroup analysis of non‐genetic paternal factors on congenital heart defects
| Exposure | No. of cases | No. of controls | Summary odds ratio (95% CI) | Heterogeneity | Funnel plot | |
|---|---|---|---|---|---|---|
| Age (years) | 7137 | 860 802 | 1.02 (1.00, 1.04) | .04 | RE | Symmetric |
| <20 | 495 | 228 352 | 1.06 (0.72, 1.54) | .01 | RE | Symmetric |
| 20‐24 | 2978 | 1 120 362 | 0.90 (0.80, 1.02) | <.0001 | RE | Symmetric |
| 25‐29 | 5745 | 1 740 888 | 0.90 (0.82, 0.98) | <.0001 | RE | Symmetric |
| 30‐34 | 4816 | 1 635 132 | 0.99 (0.90, 1.08) | .0002 | RE | Symmetric |
| 35‐39 | 2816 | 987 206 | 1.14 (1.09, 1.19) | .45 | FE | Symmetric |
| ≥40 | 2032 | 523 839 | 1.27 (1.14, 1.42) | .0001 | RE | Symmetric |
| Smoking (cigarette/day) | 8709 | 14 456 | 1.42 (1.17, 1.74) | <.0001 | RE | Asymmetric |
| 1‐9 | 434 | 597 | 1.19 (0.82, 1.71) | .003 | RE | Asymmetric |
| 10‐19 | 467 | 495 | 1.41 (1.20, 1.67) | .15 | FE | Symmetric |
| 20‐ | 1131 | 730 | 1.75 (1.10, 2.80) | <.0001 | RE | Asymmetric |
| Drinking | 13 406 | 16 430 | 1.47 (1.05, 2.07) | <.0001 | RE | Symmetric |
| Toxicant | NA | NA | 2.15 (1.53, 3.02) | <.0001 | RE | Symmetric |
Abbreviations: CI, confidence interval; FE, fixed effects model; NA, not available; OR, odds ratio; RE, random effects model.